| Lastest Insider Transactions Of T2 Biosystems, Inc. ( TTOO ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | See Remarks | 2024-02-24 | Option Exercise | 67 | 0.00 | 0 | 2024-02-27 16:31:26 |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | 2024-02-24 | Option Exercise | 29 | 0.00 | 0 | 2024-02-27 16:30:42 |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | 2024-02-24 | Option Exercise | 29 | 0.00 | 0 | 2024-02-27 16:30:37 |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | See Remarks | 2024-02-20 | Option Exercise | 160 | 0.00 | 0 | 2024-02-20 16:00:17 |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | 2023-11-08 | Option Exercise | 33 | 0.00 | 0 | 2023-11-28 16:05:19 |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | 2023-02-20 | Sell | 537 | 0.65 | 349 | 2023-11-28 16:00:04 |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | 2023-02-20 | Option Exercise | 1,333 | 0.00 | 0 | 2023-11-28 16:00:04 |
| TTOO | T2 Biosystems, Inc. | Adams Laura Lee | Directior | 2023-10-18 | Option Exercise | 7 | 0.00 | 0 | 2023-10-20 16:16:38 |
| TTOO | T2 Biosystems, Inc. | Elsbree David B | Directior | 2023-09-15 | Option Exercise | 2,300 | 0.00 | 0 | 2023-10-11 17:00:38 |
| TTOO | T2 Biosystems, Inc. | Toft Robin | Directior | 2023-09-15 | Option Exercise | 2,300 | 0.00 | 0 | 2023-10-11 17:00:35 |
| TTOO | T2 Biosystems, Inc. | CUMMING JOHN W | Directior | 2023-09-15 | Option Exercise | 2,600 | 0.00 | 0 | 2023-10-11 17:00:32 |
| TTOO | T2 Biosystems, Inc. | Saunders Ninfa | Directior | 2023-09-15 | Option Exercise | 2,300 | 0.00 | 0 | 2023-10-11 17:00:29 |
| TTOO | T2 Biosystems, Inc. | Adams Laura Lee | Directior | 2023-09-15 | Option Exercise | 2,300 | 0.00 | 0 | 2023-10-11 17:00:26 |
| TTOO | T2 Biosystems, Inc. | LIEBMAN SEYMOUR | Directior | 2023-09-15 | Option Exercise | 2,300 | 0.00 | 0 | 2023-10-11 17:00:14 |
| TTOO | T2 Biosystems, Inc. | Bernard Thierry | Directior | 2023-09-15 | Option Exercise | 2,300 | 0.00 | 0 | 2023-10-11 17:00:11 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-27 | Sell | 13,130,147 | 0.17 | 2,271,957 | 2023-09-29 16:30:16 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-26 | Sell | 5,392,920 | 0.20 | 1,082,359 | 2023-09-28 16:30:16 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-25 | Sell | 250,000 | 0.25 | 62,500 | 2023-09-27 17:53:55 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-22 | Sell | 5,079,344 | 0.26 | 1,314,534 | 2023-09-26 17:15:43 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-21 | Sell | 6,338,211 | 0.30 | 1,904,632 | 2023-09-25 20:30:09 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-20 | Sell | 7,753,710 | 0.31 | 2,408,302 | 2023-09-22 16:15:10 |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | 2023-09-19 | Sell | 10,401,466 | 0.37 | 3,806,937 | 2023-09-21 16:30:32 |
| TTOO | T2 Biosystems, Inc. | Bernard Thierry | Directior | 2023-01-01 | Option Exercise | 2,004 | 0.00 | 0 | 2023-08-16 16:01:24 |
| TTOO | T2 Biosystems, Inc. | Saunders Ninfa | Directior | 2023-01-01 | Option Exercise | 2,004 | 0.00 | 0 | 2023-08-16 16:00:49 |
| TTOO | T2 Biosystems, Inc. | Toft Robin | Directior | 2023-08-06 | Option Exercise | 454 | 0.00 | 0 | 2023-08-16 16:00:45 |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | 2023-03-28 | Sell | 239 | 0.48 | 115 | 2023-04-06 13:08:05 |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | 2023-03-24 | Option Exercise | 334 | 0.00 | 0 | 2023-04-05 14:30:18 |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | 2023-03-24 | Option Exercise | 333 | 0.00 | 0 | 2023-03-28 16:02:02 |
| TTOO | T2 Biosystems, Inc. | Adams Laura Lee | Directior | 2022-10-18 | Option Exercise | 732 | 0.00 | 0 | 2023-03-09 16:00:25 |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | 2023-02-20 | Sell | 537 | 0.65 | 349 | 2023-03-09 16:00:22 |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | 2023-02-20 | Option Exercise | 1,333 | 0.00 | 0 | 2023-03-09 16:00:22 |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | 2023-02-20 | Sell | 2,693 | 0.62 | 1,682 | 2023-03-09 16:00:18 |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | 2023-02-20 | Option Exercise | 6,914 | 0.00 | 0 | 2023-03-09 16:00:18 |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | 2023-02-20 | Sell | 3,730 | 0.62 | 2,329 | 2023-03-09 16:00:15 |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | 2023-02-20 | Option Exercise | 6,914 | 0.00 | 0 | 2023-03-09 16:00:15 |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | Chairman and CEO | 2023-02-20 | Sell | 9,773 | 0.63 | 6,179 | 2023-03-09 16:00:07 |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | Chairman and CEO | 2023-02-20 | Option Exercise | 22,667 | 0.00 | 0 | 2023-03-09 16:00:07 |
